Deprescribing psychotropic medicines for behaviours that challenge in people with intellectual disabilities: a systematic reviewDanielle Adams, Peter E. Langdon, Chetan Shah et al.|BMC Psychiatry|2023Cited by 23
Stakeholder experiences of deprescribing psychotropic medicines for challenging behaviour in people with intellectual disabilitiesDanielle Adams, Peter E. Langdon, Chetan Shah et al.|Tizard Learning Disability Review|2024Cited by 9
Pharmacists’ Perspectives on Deprescribing Psychotropic Medicines in People with Intellectual DisabilitiesDanielle Adams, Peter E. Langdon, Richard P. Hastings et al.|Journal of Mental Health Research in Intellectual Disabilities|2025Cited by 4
Factors supporting optimisation of psychotropic deprescribing in people with intellectual disabilities within the UK: a modified Delphi studyDanielle Adams, Peter E. Langdon, Ian Maidment et al.|Frontiers in Psychiatry|2025Cited by 1